Virtus Fund Advisers’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RC
BC
SFM
LAM
BIT
RA
TAM
Virtus Fund Advisers's ANGO Position: Q3 2014 in Review
Virtus Fund Advisers sold out of AngioDynamics (ANGO) in Q3 2014, closing a stake of 2,109 shares — an estimated $34K sold.
Virtus Fund Advisers first reported a position in ANGO in Q2 2014 and held it in 1 quarter. The position peaked at $34K in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.
- Virtus Fund Advisers reported no remaining AngioDynamics position as of Q3 2014 after selling out during the quarter.
- Virtus Fund Advisers sold 2,109 AngioDynamics shares in Q3 2014, an estimated $34K.
- Virtus Fund Advisers first reported a position in AngioDynamics in Q2 2014 and held it in 1 quarter.
- Virtus Fund Advisers's AngioDynamics position peaked at $34K in Q2 2014.
- 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.
Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.